美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Invesco Dorsey Wright Healthcare Momentum ETF

57.21

-1.1726-2.01%

盘后：57.240.0329+0.06%19:30 EDT

成交量：1.94万

成交额：111.97万

市值：2.80亿

市盈率：18.71

高：58.15

开：58.15

低：57.21

收：58.38

52周最高：64.10

52周最低：44.70

股本：489.00万

流通股本：489.00万

量比：0.62

换手率：0.40%

股息：1.52

股息率：2.66%

每股收益(TTM):3.06

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

营收猛增42%且扭亏为盈! 人工椎间盘领军者Centinel Spine冲刺美股IPO 创新医疗器械迎估值检验

Guardant Health Inc(GH)股票10月6日盘中下跌8.27%：背后推手曝光

TradingKey中文

Revolution Medicines启动Rasolute 309三期临床试验，评估Rasonque™（Daraxonrasib）联合Zoldonrasib一线治疗转移性Ras G12d胰腺癌

Revolution Medicines, Inc.：Leerink Partners 恢复覆盖，给予“跑赢大盘”评级，目标价 288 美元

博裕资本据悉考虑出售医疗器械制造商Quasar

山外山：全资子公司血液透析器完成医疗器械延续注册

医药“十五五”规划落地，科创板创新药、医疗器械迎政策利好

东方财富网

普门科技(688389.SH)：“光子治疗仪”取得医疗器械注册证

中信建投：医疗器械板块拐点来临

东方财富网

京东健康与GE医疗达成战略合作

科华生物：子公司获3项医疗器械注册证

普门科技：取得1个医疗器械注册证

医药韧性凸显！药ETF华宝（562050）逆市飘红，丽珠集团涨停！医疗器械局部强势，迈瑞、联影携手走强

医药工业“十五五”规划重磅发布！产业链这条赛道，核心标的净利增长2160%

东方财富网

汇禾医疗科创板IPO“终止” 主营泛血管介入领域创新医疗器械产品

先健科技(01302)：SureCham™主动脉弓单分支覆膜支架系统进入创新医疗器械特别审查程序

迈普医学：取得口腔可吸收修复膜医疗器械注册证

硕世生物(688399.SH)取得两项医疗器械注册证

迈克生物(300463.SZ)取得三项医疗器械注册证

Roivant（ROIV）跌2.93% 皮肤红斑狼疮试验失利

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/PTH/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":57.2071,"timestamp":1791921600000,"preClose":58.3797,"halted":0,"volume":19444,"hourTrading":{"tag":"盘后","latestPrice":57.24,"preClose":57.2071,"latestTime":"19:30 EDT","volume":13,"amount":743.6097,"timestamp":1791934204290,"change":0.0329,"changeRate":0.000575,"amplitude":0},"delay":0,"changeRate":-0.020085748984664236,"floatShares":4890000,"shares":4890000,"eps":3.057033,"marketStatus":"未开盘","change":-1.1726,"latestTime":"10-13 16:00:00 EDT","open":58.15,"high":58.15,"low":57.2071,"amount":1119702.5728799999,"amplitude":0.016151,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791964800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":58.3797,"sharesOutstanding":2480000,"nav":58.3625,"aum":285976250,"dividendRate":0.026635,"bidAskSpread":0.002069,"postHourTrading":{"tag":"盘后","latestPrice":57.24,"preClose":57.2071,"latestTime":"19:30 EDT","volume":13,"amount":743.6097,"timestamp":1791934204290,"change":0.0329,"changeRate":0.000575,"amplitude":0},"volumeRatio":0.623181,"impliedVol":0.1088,"impliedVolPercentile":0.3665},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4890000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.623181,"shares":4890000,"dividePrice":1.5237,"high":58.15,"amplitude":0.016151,"preClose":58.3797,"low":57.2071,"week52Low":44.7,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":57.2071,"eps":3.057033,"divideRate":0.026635,"volume":19444,"delay":0,"ttmEps":3.057033,"open":58.15,"prevYearClose":49.701,"prevWeekClose":58.757,"prevMonthClose":60.76,"prevQuarterClose":60.76,"fiveDayClose":58.5628,"twentyDayClose":60.8034,"sixtyDayClose":58.2213},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673293026","title":"营收猛增42%且扭亏为盈! 人工椎间盘领军者Centinel Spine冲刺美股IPO 创新医疗器械迎估值检验","url":"https://stock-news.laohu8.com/highlight/detail?id=2673293026","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673293026?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 14:44","pubTimestamp":1791441889,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国知名医疗器械制造商Centinel Spine当地时间周三在提交的美国股市首次公开募股申报文件中披露，上半年营收大幅增长42%。Centinel Spine此次递交IPO申请，可谓为全球聚焦于医疗器械的投资者们提供了一个“技术商业化、收入增长与盈利改善同步加速推进”的观察样本。目前该公司尚未完成IPO发行与最终的估值定价。Centinel Spine计划将此次发行募集的资金用于偿还债务，并投资于销售基础设施、患者宣传教育项目、临床试验等方面。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504538.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LGHT","AGNG","PTH","REDS","MEDX","HART","FRHC","IEIH","LNGR","GDOC","09996","KCE","IPOS","159883","MDEV","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673068734","title":"Guardant Health Inc(GH)股票10月6日盘中下跌8.27%：背后推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2673068734","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673068734?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 03:16","pubTimestamp":1791314179,"startTime":"0","endTime":"0","summary":"• 经过连续数月的反弹后，获利回吐导致 Guardant Health 股价下跌。\n• 持续亏损和高估值倍数引发了沉重的抛盘压力。\n• 该公司报告的年营收为 9.8202 亿美元，净利润为 -4.1628 亿美元。","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262202425-market-movers-gh-20261006","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","LU0889565916.HKD","BK4535","LFSC","BK4551","GDOC","HELX","BK4196","EKG","FFOX","LU0109394709.USD","BK4585","GNMX","GH","BK4588","GNOM","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146110262","title":"Revolution Medicines启动Rasolute 309三期临床试验，评估Rasonque™（Daraxonrasib）联合Zoldonrasib一线治疗转移性Ras G12d胰腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1146110262","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146110262?lang=zh_cn&edition=fundamental","pubTime":"2026-10-05 20:01","pubTimestamp":1791201670,"startTime":"0","endTime":"0","summary":"Revolution Medicines公司已开始对患者进行治疗，正式启动Rasolute 309三期临床试验。该试验旨在评估Rasonque™（Daraxonrasib）与Zoldonrasib联合用药方案，作为转移性Ras G12d胰腺癌患者的一线治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","IE00BJT1NW94.SGD","BK4139","LU0320765992.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","PTH","IE00B4R5TH58.HKD","LU0889565916.HKD","IE0009355771.USD","IE0009354923.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BBH","RVMD","IDNA","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106947229","title":"Revolution Medicines, Inc.：Leerink Partners 恢复覆盖，给予“跑赢大盘”评级，目标价 288 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1106947229","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106947229?lang=zh_cn&edition=fundamental","pubTime":"2026-10-05 18:12","pubTimestamp":1791195132,"startTime":"0","endTime":"0","summary":"Revolution Medicines, Inc.：Leerink Partners 恢复覆盖，给予“跑赢大盘”评级，目标价 288 美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","CANC","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","IE0009354923.USD","IE00BJJMRZ35.SGD","IDNA","LU0320765992.SGD","IE0009355771.USD","PTH","LU0889565916.HKD","IE0002141913.USD","BK4139","RVMD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673670370","title":"博裕资本据悉考虑出售医疗器械制造商Quasar","url":"https://stock-news.laohu8.com/highlight/detail?id=2673670370","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673670370?lang=zh_cn&edition=fundamental","pubTime":"2026-10-05 16:16","pubTimestamp":1791188170,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159883","LNGR","BK1574","GDOC","MEDX","RSPH","09996","HART","AGNG","IEIH","PTH","LGHT","MDEV","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671274689","title":"山外山：全资子公司血液透析器完成医疗器械延续注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2671274689","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671274689?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 16:29","pubTimestamp":1790756958,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","GDOC","RSPH","IEIH","LGHT","HART","PTH","AGNG","MDEV","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211883","title":"医药“十五五”规划落地，科创板创新药、医疗器械迎政策利好","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211883","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211883?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 19:41","pubTimestamp":1790682114,"startTime":"0","endTime":"0","summary":"近日，工业和信息化部等十部门联合印发《医药工业发展“十五五”规划》（以下简称《规划》），对“十五五”时期我国医药工业高质量发展作出系统性部署。《规划》围绕创新驱动、韧性安全、数智转型等八大方向部署25项重点任务，为创新药、医疗器械等细分行业进一步明确了长期发展路线。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://finance.eastmoney.com/news/1354,202609293886609720.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202609293886609720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["RSPH","09939","IBBQ","MDEV","BK1583","BK1100","IEIH","159883","09996","AGNG","HART","GDOC","KSTR","BK1515","159992","MEDX","BK1161","06978","BK1574","159938","LGHT","LNGR","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671903742","title":"普门科技(688389.SH)：“光子治疗仪”取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2671903742","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671903742?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 17:18","pubTimestamp":1790673523,"startTime":"0","endTime":"0","summary":"智通财经APP讯，普门科技(688389.SH)发布公告，公司控股子公司重庆普门创生物技术有限公司于近期收到了重庆市药品监督管理局颁发的《中华人民共和国医疗器械注册证》，该产品为：“光子治疗仪”。上述取得注册证的光子治疗仪，可输出高能窄谱红光和蓝光，支持多种治疗模式，以满足不同用户治疗需求。该产品适用于需要消炎、镇痛，对体表创面止渗液、促进肉芽组织生长、加速愈合的患者，可以在医院科室、诊所、家庭等多种场所使用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688389","159883","BK1100","HART","GDOC","LGHT","MDEV","09996","IEIH","LNGR","PTH","BK1574","MEDX","RSPH","BK0251","BK1583","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671612264","title":"中信建投：医疗器械板块拐点来临","url":"https://stock-news.laohu8.com/highlight/detail?id=2671612264","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671612264?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 08:50","pubTimestamp":1790643046,"startTime":"0","endTime":"0","summary":"中信建投证券研报认为，医疗器械板块的长期投资机会来自创新、出海和并购整合，板块的创新性和国际化能力得到认可，估值正在被重估。创新药板块大涨之后，医疗器械板块具有全球竞争力的改进式创新、突破式创新的产品正在被逐步认可，也有一批公司积极战略拓展第二增长曲线、实现海外业务高增长，估值迎来上涨。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11215,202609293885901238.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11215,202609293885901238.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["HART","09996","LNGR","BK1583","LGHT","AGNG","MDEV","159883","BK1100","BK0276","601066","IEIH","BK1574","RSPH","MEDX","GDOC","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670329032","title":"京东健康与GE医疗达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2670329032","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670329032?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 20:08","pubTimestamp":1790597296,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0077335932.USD","AGNG","LU0640476718.USD","LU2168564065.EUR","LU1093756325.SGD","RSPH","BK4543","GDOC","MDEV","NATO","PTH","IEIH","LU0354030438.USD","LU1261432733.SGD","LU1066053197.SGD","GE","LU1119994496.HKD","LGHT","LU0820562030.AUD","LU2168563687.JPY","LU0353189680.USD","UXI","MEDX","LU0267386448.USD","BK4566","HART","LU1366333091.USD","TRUI","LU1066051811.HKD","LU2264538146.SGD","LU1093756168.USD","LU1280957306.USD","BK4206","LU0820561818.USD","BK4187","LU2168564222.USD","LU2756315318.SGD","LU1084165304.USD","EXI","LNGR","DFEN","XAR","BK4501","LU0820561909.HKD","LU1064131342.USD","LU0157215616.USD","ITA","PPA","MISL","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670233923","title":"科华生物：子公司获3项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2670233923","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670233923?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 17:27","pubTimestamp":1790587665,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","IEIH","MDEV","LGHT","LNGR","GDOC","RSPH","MEDX","PTH","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670238403","title":"普门科技：取得1个医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2670238403","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670238403?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 17:06","pubTimestamp":1790586364,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PTH","LNGR","RSPH","AGNG","LGHT","MEDX","MDEV","HART","IEIH","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670286537","title":"医药韧性凸显！药ETF华宝（562050）逆市飘红，丽珠集团涨停！医疗器械局部强势，迈瑞、联影携手走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2670286537","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670286537?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 13:11","pubTimestamp":1790572260,"startTime":"0","endTime":"0","summary":"制药板块顽强抗跌，场内唯一跟踪制药指数的药ETF华宝一度逆市飘红，创新药概念股丽珠集团涨停封板，健康元、康弘药业、普洛药业齐涨逾5%。把握超跌医药新机遇，投资工具关注：药ETF华宝：全市场唯一跟踪制药指数的ETF，“70%创新药+20%中药”独家配比，兼具创新药高成长及中药高股息。医疗ETF华宝：全市场医药医疗类ETF旗舰，Q2规模256.24亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-28/doc-initkarm3859610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0187","562050","159883","LGHT","PTH","HART","IEIH","AGNG","BK0028","000513","LNGR","MEDX","BK0188","BK0239","09939","BK1161","RSPH","BK1100","09996","BK1515","BK1583","159938","MDEV","BK1574","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670428262","title":"医药工业“十五五”规划重磅发布！产业链这条赛道，核心标的净利增长2160%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670428262","media":"东方财富网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670428262?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 20:42","pubTimestamp":1790340148,"startTime":"0","endTime":"0","summary":"2026年以来，体外诊断（长江）指数已经上涨了13.18%。当6月下旬以来创新药与CRO联手掀起一轮医药高潮后，投资者与产业圈的人士也在纷纷深挖医药产业链，寻找一条更具性价比的细分赛道。如今医疗器械赛道有望成为第三选择，其中的代表是IVD(体外诊断)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://finance.eastmoney.com/news/1354,202609253884319375.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202609253884319375.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["RSPH","BK1100","BK1574","GDOC","IEIH","MDEV","LNGR","HART","MEDX","BK1583","IBBQ","AGNG","09996","PTH","BK1161","06978","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669728498","title":"汇禾医疗科创板IPO“终止” 主营泛血管介入领域创新医疗器械产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2669728498","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669728498?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 20:40","pubTimestamp":1790253623,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，9月24日，上海汇禾医疗科技股份有限公司上交所科创板IPO审核状态变更为“终止”。因汇禾医疗及其保荐人撤回发行上市申请，根据《上海证券交易所股票发行上市审核规则》第六十三条有关规定，上交所终止其发行上市审核。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500743.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MEDX","AGNG","IEIH","IPOS","PTH","KSTR","GDOC","MDEV","BK1100","BK1574","FRHC","HART","BK1583","159883","BK4127","RSPH","REDS","LNGR","159891","LGHT","09996","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669602624","title":"先健科技(01302)：SureCham™主动脉弓单分支覆膜支架系统进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2669602624","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669602624?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 20:12","pubTimestamp":1790251926,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先健科技 发布公告，于2026年9月24日，本公司收到国家药品监督管理局的正式书面通知，确认由本公司与国家心血管病中心中国医学科学院阜外医院舒畅教授团队联合研发的SureCham主动脉弓单分支覆膜支架系统进入国家药品监督管理局创新医疗器械特别审查程序(该程序)。该产品适用于治疗累及主动派弓部的主动脉夹层，为本公司第十九个进入国家药品监督管理局该程序的产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LGHT","01302","PTH","AGNG","RSPH","GDOC","HART","BK1574","09996","BK1100","BK1600","LNGR","MEDX","MDEV","159883","IEIH","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669469423","title":"迈普医学：取得口腔可吸收修复膜医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2669469423","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669469423?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 17:54","pubTimestamp":1790243657,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","LGHT","IEIH","LNGR","RSPH","MEDX","GDOC","MDEV","PTH","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669838466","title":"硕世生物(688399.SH)取得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2669838466","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669838466?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 17:17","pubTimestamp":1790241437,"startTime":"0","endTime":"0","summary":"智通财经APP讯，硕世生物(688399.SH)发布公告，公司近日收到国家药品监督管理局签发的医疗器械注册证(体外诊断试剂)，产品名称：丙型肝炎病毒核酸检测试剂盒(荧光PCR法)、基孔肯雅病毒核酸检测试剂盒(荧光PCR法)。上述《医疗器械注册证》的取得，丰富了公司产品种类，扩充了公司在体外诊断领域的布局，不断满足多元化的临床需求，将增强公司综合竞争力，有利于进一步提高公司的市场拓展能力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500500.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MDEV","159883","BK0239","LGHT","HART","MEDX","RSPH","09996","BK1574","GDOC","PTH","AGNG","LNGR","BK1583","IEIH","BK1100","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669878465","title":"迈克生物(300463.SZ)取得三项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2669878465","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669878465?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 16:50","pubTimestamp":1790239833,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈克生物(300463.SZ)发布公告，公司于近日收到四川省药品监督管理局颁发的三项《医疗器械注册证》，分别为总Ⅰ型胶原氨基端延长肽测定试剂盒(直接化学发光法)、β-胶原特殊序列测定试剂盒(直接化学发光法)、骨钙素测定试剂盒(直接化学发光法)。三款产品均系公司直接化学发光平台新试剂产品，主要用于骨质疏松的辅助诊断。截至目前，公司在直接化学发光平台下已累计取得145项试剂类产品注册证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","GDOC","159883","PTH","AGNG","LNGR","BK0239","IEIH","HART","BK0046","MEDX","09996","MDEV","300463","BK1583","LGHT","BK0028","RSPH","BK1100","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669485368","title":"Roivant（ROIV）跌2.93% 皮肤红斑狼疮试验失利","url":"https://stock-news.laohu8.com/highlight/detail?id=2669485368","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669485368?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 20:06","pubTimestamp":1790165207,"startTime":"0","endTime":"0","summary":"金吾财讯 | Roivant Sciences 美股盘前股价承压，最新跌2.93%，报37.1美元。消息面上，Roivant旗下子公司Immunovant的在研药物IMVT-1402针对皮肤自身免疫疾病-皮肤红斑狼疮的概念验证临床试验宣告失败。公司公布的12周试验数据显示，这项纳入57名受试者的研究，未能达成基于皮肤红斑狼疮疾病面积与严重程度活动指数评分设定的主要终点。受本次试验结果以及皮肤红斑狼疮领域行业竞争影响，Immunovant将不再继续推进IMVT-1402项目。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/NmJhNzAzYmFlYjJhNGNmZDhhMTE1NWJmMTYxODM5M2UxMzU2NDM2MDM2MQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NmJhNzAzYmFlYjJhNGNmZDhhMTE1NWJmMTYxODM5M2UxMzU2NDM2MDM2MQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306391","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","ROIV","BK4007","IMVT","PTH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}